Total investments received (USD): N/A
Round value (USD): N/A
Round investors:
Nucleus Capital
Company: Officinae Bio




Belgium
Netherlands
Austria
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
Ireland
Portugal
Spain
United Kingdom